Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-16

Clinical Trial Update: Tocilizumab Effect on microRNA Expression and Adipokine Levels in Rheumatoid Arthritis Patients

View source ↗

Summary

A clinical trial evaluating the effect of tocilizumab on microRNA expression and adipokine levels in rheumatoid arthritis patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tocilizumab (tocilizumab)

Snippet

Sponsor: Carmel Medical Center | Conditions: Rheumatoid Arthritis | Status: COMPLETED